Skip to main content
Erschienen in: Abdominal Radiology 8/2020

07.08.2019 | Hollow Organ GI

Diffusion-weighted magnetic resonance for assessing fibrosis in Crohn’s disease

verfasst von: Antonino Caruso, Imerio Angriman, Marco Scarpa, Renata D’Incà, Claudia Mescoli, Massimo Rudatis, Giacomo Carlo Sturniolo, Giovanni Schifano, Carmelo Lacognata

Erschienen in: Abdominal Radiology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Intestinal fibrosis is a key feature of Crohn’s Disease lesions, and mucosal biopsies do not exactly represent transmural damage. Magnetic resonance enterography (MRE) allows for a panoramic study of the bowel loops. Diffusion-weighted imaging (DWI) through the restriction of the apparent diffusion coefficient (ADC) allows for an accurate evaluation of disease activity in Crohn’s Disease patients avoiding contrast agents. The aim of this study was to investigate whether DWI sequences were able to identify intestinal fibrosis in candidates for surgery, using histopathology as the gold standard.

Materials and methods

Thirty Crohn’s Disease patients undergoing surgery for stricturing ileo-colonic disease were consecutively enrolled from October 2010 to November 2015. All patients underwent MRE with DWI before surgery. Radiological parameters were calculated in the stenotic segment and in the ileum proximal to the stenosis. The histopathological examination was performed using a histological score for fibrosis and inflammation.

Results

ADC value correlated with the fibrosis score (r = −0.648; p < 0.0001), inflammation score (r = −0.763; p < 0.0001) and percentage of gain (r = −0.687; p < 0.0001). A correlation emerged between wall thickness and fibrosis score (r = 0.671; p < 0.0001). The threshold of wall thickness for fibrosis was > 6.3 mm (AUC 0.89, specificity 100% and sensitivity 69.23%). The cut-off of ADC value for fibrosis was < 1.1 × 10−3 mm2 s−1 with a sensitivity of 72% and specificity of 94% (AUC = 0.83).

Conclusions

The DWI sequence with ADC value could be useful to identify fibrosis in the intestinal wall of Crohn’s Disease patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Pellino G, Pallante P, Selvaggi F. Novel biomarkers of fibrosis in Crohn’s disease. World J Gastrointest Pathophysiol 2016; 7(3): 266-275.CrossRef Pellino G, Pallante P, Selvaggi F. Novel biomarkers of fibrosis in Crohn’s disease. World J Gastrointest Pathophysiol 2016; 7(3): 266-275.CrossRef
2.
Zurück zum Zitat Rimola J, Planell N, Rodriguez S, Delgado S, Ordás I, Ramírez-Morros A, Ayuso C, Aceituno M et al. Characterization of inflammation and fibrosis in Crohn’s Disease lesions by magnetic resonance imaging. Am J Gastroenterol 2015; 110:432–440.CrossRef Rimola J, Planell N, Rodriguez S, Delgado S, Ordás I, Ramírez-Morros A, Ayuso C, Aceituno M et al. Characterization of inflammation and fibrosis in Crohn’s Disease lesions by magnetic resonance imaging. Am J Gastroenterol 2015; 110:432–440.CrossRef
3.
Zurück zum Zitat Panes J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC et al. Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis. 2013;7(7):556-85.CrossRef Panes J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC et al. Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis. 2013;7(7):556-85.CrossRef
4.
Zurück zum Zitat Rieder F, de Bruyn JR, Pham BT,Katsanos K, Annese V, Higgins PD et al. Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease. J Crohns Colitis. 2014;8(10):1166-78.CrossRef Rieder F, de Bruyn JR, Pham BT,Katsanos K, Annese V, Higgins PD et al. Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease. J Crohns Colitis. 2014;8(10):1166-78.CrossRef
5.
Zurück zum Zitat Punwani S, Rodriguez-Justo M, Bainbridge A, Greenhalgh R, De Vita E, Bloom S, Cohen R et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology.2009;252(3):712-20.CrossRef Punwani S, Rodriguez-Justo M, Bainbridge A, Greenhalgh R, De Vita E, Bloom S, Cohen R et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology.2009;252(3):712-20.CrossRef
6.
Zurück zum Zitat Zappa M, Stefanescu C, Cazals-Hatem D, Bretagnol F, Deschamps L, Attar A et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn’s disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis. 2011;17(4):984-93.CrossRef Zappa M, Stefanescu C, Cazals-Hatem D, Bretagnol F, Deschamps L, Attar A et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn’s disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis. 2011;17(4):984-93.CrossRef
7.
Zurück zum Zitat Kim KJ, Lee Y, Park SH, Kang BK, Seo N, Yang SK et al. Diffusion-weighted MR enterography for evaluating Crohn’s disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis. 2015;21(1):101-9.CrossRef Kim KJ, Lee Y, Park SH, Kang BK, Seo N, Yang SK et al. Diffusion-weighted MR enterography for evaluating Crohn’s disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis. 2015;21(1):101-9.CrossRef
8.
Zurück zum Zitat Caruso A, DʼIncà R, Scarpa M, Manfrin P, Rudatis M, Pozza Aet al. Diffusion-weighted magnetic resonance for assessing ileal Crohn’s disease activity. Inflamm Bowel Dis. 2014;20(9):1575-83.CrossRef Caruso A, DʼIncà R, Scarpa M, Manfrin P, Rudatis M, Pozza Aet al. Diffusion-weighted magnetic resonance for assessing ileal Crohn’s disease activity. Inflamm Bowel Dis. 2014;20(9):1575-83.CrossRef
9.
Zurück zum Zitat Tielbeek JA, Ziech ML, Li Z, Lavini C, Bipat S, Bemelman WA et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol. 2014;24(3):619-29.CrossRef Tielbeek JA, Ziech ML, Li Z, Lavini C, Bipat S, Bemelman WA et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol. 2014;24(3):619-29.CrossRef
10.
Zurück zum Zitat Rosenbaum DG, Rose ML, Solomon AB, Giambrone AE, Kovanlikaya A. Longitudinal diffusion-weighted imaging changes in children with small bowel Crohn’s disease: preliminary experience. Abdom Imaging. 2015;40(5):1075-80.CrossRef Rosenbaum DG, Rose ML, Solomon AB, Giambrone AE, Kovanlikaya A. Longitudinal diffusion-weighted imaging changes in children with small bowel Crohn’s disease: preliminary experience. Abdom Imaging. 2015;40(5):1075-80.CrossRef
11.
Zurück zum Zitat Kovanlikaya A, Beneck D, Rose M, Renjen P, Dunning A, Solomon A et al. Quantitative apparent diffusion coefficient (ADC) values as an imaging biomarker for fibrosis in pediatric Crohn’s disease: preliminary experience. Abdom Imaging. 2015;40(5):1068-74.CrossRef Kovanlikaya A, Beneck D, Rose M, Renjen P, Dunning A, Solomon A et al. Quantitative apparent diffusion coefficient (ADC) values as an imaging biomarker for fibrosis in pediatric Crohn’s disease: preliminary experience. Abdom Imaging. 2015;40(5):1068-74.CrossRef
12.
Zurück zum Zitat Rimola J, Rodriguez S, García-Bosch O, Ordás I, Ayala E, Aceituno M et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009;58:1113–1120.CrossRef Rimola J, Rodriguez S, García-Bosch O, Ordás I, Ayala E, Aceituno M et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009;58:1113–1120.CrossRef
13.
Zurück zum Zitat Buisson A, Joubert A, Montoriol PF, Da Ines D, Hordonneau C, Pereira C et al. Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn’s disease. Aliment Pharmacol Ther. 2013;37:537–545.CrossRef Buisson A, Joubert A, Montoriol PF, Da Ines D, Hordonneau C, Pereira C et al. Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn’s disease. Aliment Pharmacol Ther. 2013;37:537–545.CrossRef
14.
Zurück zum Zitat Borley NR, Mortensen NJ, Jewell DP, Warren BF. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn’s disease: evidence for a possible causative link. J Pathol 2000;190(2):196-202.CrossRef Borley NR, Mortensen NJ, Jewell DP, Warren BF. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn’s disease: evidence for a possible causative link. J Pathol 2000;190(2):196-202.CrossRef
15.
Zurück zum Zitat Chioren MV, Sandrasegaran K, Saxena R, Maglinte DD, Nakeeb A, Johnson CS. Correlation of CT enteroclysis with surgical pathology in Crohn’s disease. Am J Gastroenterol. 2007;102(11):2541-50.CrossRef Chioren MV, Sandrasegaran K, Saxena R, Maglinte DD, Nakeeb A, Johnson CS. Correlation of CT enteroclysis with surgical pathology in Crohn’s disease. Am J Gastroenterol. 2007;102(11):2541-50.CrossRef
16.
Zurück zum Zitat Henderson AR. Assessing test accuracy on its clinical consequence: a primer for receiver operating characteristics curve analysis. Ann Clin Biochem. 1993;30:521–539.CrossRef Henderson AR. Assessing test accuracy on its clinical consequence: a primer for receiver operating characteristics curve analysis. Ann Clin Biochem. 1993;30:521–539.CrossRef
17.
Zurück zum Zitat Bettenworth D, Nowacki TM, Cordes F, Buerke B, Lenze F. Assessment of stricturing Crohn’s disease: Current clinical practice and future avenues. World J Gastroenterol. 2016;22(3):1008-16.CrossRef Bettenworth D, Nowacki TM, Cordes F, Buerke B, Lenze F. Assessment of stricturing Crohn’s disease: Current clinical practice and future avenues. World J Gastroenterol. 2016;22(3):1008-16.CrossRef
18.
Zurück zum Zitat Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-1794.CrossRef Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-1794.CrossRef
19.
Zurück zum Zitat Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut 2005; 54: 237-241.CrossRef Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut 2005; 54: 237-241.CrossRef
20.
Zurück zum Zitat Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sandborn WJ, Loftus EV Jr. Surgery in a population-based cohort of Crohn’s disease from Olmsted County, Minnesota (1970-2004). Am J Gastroenterol 2012; 107: 1693-1701.CrossRef Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sandborn WJ, Loftus EV Jr. Surgery in a population-based cohort of Crohn’s disease from Olmsted County, Minnesota (1970-2004). Am J Gastroenterol 2012; 107: 1693-1701.CrossRef
21.
Zurück zum Zitat Fornasa F, Benassutti C, Benazzato L. Role of Magnetic Resonance Enterography in Differentiating between Fibrotic and Active Inflammatory Small Bowel Stenosis in Patients with Crohn’s Disease. J Clin Imaging Sci. 2011. Fornasa F, Benassutti C, Benazzato L. Role of Magnetic Resonance Enterography in Differentiating between Fibrotic and Active Inflammatory Small Bowel Stenosis in Patients with Crohn’s Disease. J Clin Imaging Sci. 2011.
22.
Zurück zum Zitat Dohan A, Taylor S, Hoeffel C, Barret M, Allez M, Dautry R, Zappa M et al. Diffusion-weighted MRI in Crohn’s disease: Current status and recommendations. J Magn Reson Imaging. 2016;44(6):1381-1396.CrossRef Dohan A, Taylor S, Hoeffel C, Barret M, Allez M, Dautry R, Zappa M et al. Diffusion-weighted MRI in Crohn’s disease: Current status and recommendations. J Magn Reson Imaging. 2016;44(6):1381-1396.CrossRef
23.
Zurück zum Zitat Hordonneau C, Buisson A, Scanzi J, Goutorbe F, Pereira B, Borderon C et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity. Am J Gastroenterol. 2014;109:89–98.CrossRef Hordonneau C, Buisson A, Scanzi J, Goutorbe F, Pereira B, Borderon C et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity. Am J Gastroenterol. 2014;109:89–98.CrossRef
24.
Zurück zum Zitat Xue-hua L, Ren M, Si-yun H, et al. Characterization of degree of intestinal fibrosis in patients with Crohn Disease by using Magnetization Transfer MR Imaging. Radiology. 2018;287(2):494-503.CrossRef Xue-hua L, Ren M, Si-yun H, et al. Characterization of degree of intestinal fibrosis in patients with Crohn Disease by using Magnetization Transfer MR Imaging. Radiology. 2018;287(2):494-503.CrossRef
Metadaten
Titel
Diffusion-weighted magnetic resonance for assessing fibrosis in Crohn’s disease
verfasst von
Antonino Caruso
Imerio Angriman
Marco Scarpa
Renata D’Incà
Claudia Mescoli
Massimo Rudatis
Giacomo Carlo Sturniolo
Giovanni Schifano
Carmelo Lacognata
Publikationsdatum
07.08.2019
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 8/2020
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02167-0

Weitere Artikel der Ausgabe 8/2020

Abdominal Radiology 8/2020 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.